Kimi Iguchi, CFO & Treasurer at Sage Therapeutics, Inc. (SAGE), sold 22,064 shares at $143.09 ($3.2M) on 2018-04-26, disclosed to the SEC on 2018-04-27.
Open-market sale of $3.2M SAGE by CFO & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.21 | 100 | $14K | 0.4% |
| 2 | $143.09 | 3,207 | $459K | 14.4% |
| 3 | $143.09 | 3,207 | $459K | 14.4% |
| 4 | $143.90 | 3,300 | $475K | 14.9% |
| 5 | $144.98 | 6,075 | $881K | 27.7% |
| 6 | $144.98 | 6,075 |
| $881K |
| 27.7% |
| 7 | $145.80 | 100 | $15K | 0.5% |
| Total | $144.26 avg | 22,064 | $3.2M | 100% |
| Filing → |
| SAGE | SELL | 2017-01-13 | $539K | — | Filing → |
| SAGE | SELL | 2016-11-18 | $207K | — | Filing → |
| SAGE | SELL | 2016-11-14 | $76K | — | Filing → |